Prevalence of and Characteristics Associated With Overbasalization Among Patients With Type 2 Diabetes Using Basal Insulin: A Cross-Sectional Study-Reference-Cited by-同舟云学术

Prevalence of and Characteristics Associated With Overbasalization Among Patients With Type 2 Diabetes Using Basal Insulin: A Cross-Sectional Study

Published:2021-04-01 Issue:2 Volume:39 Page:173-175
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Cowart Kevin¹²^ORCID,Updike Wendy H.¹³,Pathak Rashmi⁴

Affiliation:

1. Department of Pharmacotherapeutics & Clinical Research, Taneja College of Pharmacy, University of South Florida, Tampa, FL

2. Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL

3. Department of Family Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL

4. College of Public Health, University of South Florida, Tampa, FL

Abstract

This article describes a cross-sectional analysis of 655 patients to determine the prevalence of and patient-specific characteristics associated with overbasalization in patients with type 2 diabetes. Overbasalization was defined as uncontrolled A1C (>8%) plus a basal insulin dose >0.5 units/kg/day. The period prevalence of overbasalization was found to be 38.1, 42.7, and 42% for those with an A1C >8, ≥9, and ≥10%, respectively. Those with an A1C ≥9% had the greatest likelihood of experiencing overbasalization. These results suggest that overbasalization may play a role in patients not achieving optimal glycemic control in type 2 diabetes.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/39/2/173/501357/diaclincd200080.pdf

Reference8 articles.

1. Overbasalization: addressing hesitancy in treatment intensification beyond basal insulin;Cowart;Clin Diabetes,2020

2. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2020;American Diabetes Association;Diabetes Care,2020

3. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2020 executive summary;Garber;Endocr Pract,2020

4. When basal insulin is not enough: a dose-response relationship between insulin glargine 100 units/mL and glycaemic control;Umpierrez;Diabetes Obes Metab,2019

5. Insulin therapy in type 2 diabetes mellitus: a practical approach for primary care physicians and other health care professionals;LaSalle;J Am Osteopath Assoc,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simplification of Complex Insulin Regimens with IdegLira in People with Type 2 Diabetes: Literature Review and Clinical Recommendations;Diabetes Therapy;2023-09-22

2. Relationship Between Daytime Versus Nighttime Continuous Glucose Monitoring Metrics with A1C in Adults with Type 1 Diabetes;Diabetes Technology & Therapeutics;2023-01-01

3. Addressing Overbasalization to Achieve Glycemic Targets;ADCES in Practice;2022-01-31

4. Practicable Measurement and Identification of Overbasalization;Clinical Diabetes;2022-01-01